Evaxion biotech strengthens management team with two senior appointments

Copenhagen, denmark, march 14, 2022 (globe newswire) -- evaxion biotech a/s (nasdaq: evax) is a clinical-stage biotechnological company specializing in the development of ai-powered immunotherapies to improve the lives of patients with cancer and infectious diseases.
EVAX Ratings Summary
EVAX Quant Ranking